CDY 1.43% 7.1¢ cellmid limited

RESEARCH ARTICLE...

  1. 458 Posts.
    lightbulb Created with Sketch. 130
    RESEARCH ARTICLE
    https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.22576
    Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer‐associated malignant pleural effusionFan Zhang  Junjun Wang  Xiaoyong Zheng  Lijuan Hu  Jie Chen

    First published: 23 May 2018

    https://doi.org/10.1002/jcla.22576[/BCOLOR]

    Abstract
    Background

    Midkine (MK) level has been shown to be elevated in serum of patients with nonsmall cell lung cancer (NSCLC). However, the diagnostic value of MK in pleural effusion in NSCLC has not been well validated and established. detection of pMK + pCA125 + pADA suggested that the sensitivity, specificity, and AUC was 82.54%, 74.19% at the cutoff 0.47 and diagnostic performance was higher than others.

    Conclusion
    Joint detection of pMK + pCA125 + pADA can be used as a good indicator for the identification of MPE of NSCLC.
    Last edited by mightypirate: 27/05/18
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.